category	term	number_of_genes	number_of_genes_in_background	ncbiTaxonId	inputGenes	preferredNames	p_value	fdr	description
PMID	PMID:37656691	16	163	9606	9606.ENSP00000246792,9606.ENSP00000246868,9606.ENSP00000260947,9606.ENSP00000262662,9606.ENSP00000264233,9606.ENSP00000269571,9606.ENSP00000287598,9606.ENSP00000298139,9606.ENSP00000305480,9606.ENSP00000324856,9606.ENSP00000330349,9606.ENSP00000332353,9606.ENSP00000336701,9606.ENSP00000358464,9606.ENSP00000372023,9606.ENSP00000406229	RRAS,SBDS,BARD1,CDKN2C,POLQ,ERBB2,BUB1B,WRN,FEN1,STK11,DDX41,PTCH1,RAD51C,SHOC2,CHEK2,FAT1	1e-13	3.89e-07	(2023) Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.
PMID	PMID:31883794	17	197	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000269571,9606.ENSP00000283928,9606.ENSP00000306522,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000331040,9606.ENSP00000332353,9606.ENSP00000336701,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000398698,9606.ENSP00000410402,9606.ENSP00000432511	IFNG,MDM2,ERBB2,JAZF1,CAMTA1,SUZ12,EZH2,STK11,CD28,OLIG2,PTCH1,RAD51C,GATA3,CHEK2,TNF,MAP2K4,JAK3	1.14e-13	3.89e-07	(2020) A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
PMID	PMID:24792170	16	160	9606	9606.ENSP00000244537,9606.ENSP00000258149,9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000298139,9606.ENSP00000310356,9606.ENSP00000333277,9606.ENSP00000336701,9606.ENSP00000356405,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000378699,9606.ENSP00000405890,9606.ENSP00000410402,9606.ENSP00000494373	H4C6,MDM2,CDK2,NCOR1,ERBB2,WRN,RMI2,H3C13,RAD51C,CDC73,GATA3,CHEK2,CDK1,PBX1,MAP2K4,MTAP	7.69e-14	3.89e-07	(2014) A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy.
PMID	PMID:36016958	12	72	9606	9606.ENSP00000053243,9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000339527,9606.ENSP00000351255,9606.ENSP00000376197,9606.ENSP00000398698,9606.ENSP00000497102	TNFRSF17,IFNG,TCF3,EZH2,EBF1,CD28,H3C13,FOXO3,STAT4,TFRC,TNF,CTLA4	4.89e-13	6.19e-07	(2022) B-cell response in solid organ transplantation.
PMID	PMID:34322780	12	80	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000269571,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,MDM2,ERBB2,STK11,CD28,ICOSLG,STAT4,GATA3,CHEK2,PRF1,TNF,CTLA4	1.5e-12	8.24e-07	(2021) Breast cancer resistance mechanisms: challenges to immunotherapy.
PMID	PMID:34788920	14	128	9606	9606.ENSP00000239938,9606.ENSP00000263464,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000330349,9606.ENSP00000358501,9606.ENSP00000358799,9606.ENSP00000363689,9606.ENSP00000365858,9606.ENSP00000376276,9606.ENSP00000376544,9606.ENSP00000406229,9606.ENSP00000432511	EGR1,BIRC3,SUZ12,EZH2,CD28,DDX41,CD58,RBM15,ID3,GATA1,SRSF2,CD79B,FAT1,JAK3	9.78e-13	8.24e-07	(2021) [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
PMID	PMID:35008340	13	104	9606	9606.ENSP00000053243,9606.ENSP00000221972,9606.ENSP00000263464,9606.ENSP00000268712,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000358799,9606.ENSP00000376544,9606.ENSP00000405574,9606.ENSP00000410481,9606.ENSP00000432511	TNFRSF17,CD79A,BIRC3,NCOR1,SUZ12,EZH2,CD28,H3C13,RBM15,CD79B,TBL1XR1,LTB,JAK3	1.39e-12	8.24e-07	(2021) Recent Advances in the Genetic of MALT Lymphomas.
PMID	PMID:32743345	13	104	9606	9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000305480,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000332353,9606.ENSP00000354522,9606.ENSP00000356832,9606.ENSP00000376276,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000432511,9606.ENSP00000494373	CDK2,ERBB2,FEN1,EZH2,STK11,PTCH1,TOP1,SGK1,SRSF2,CDK1,TNF,JAK3,MTAP	1.39e-12	8.24e-07	(2020) PRMT5 function and targeting in cancer.
PMID	PMID:32882916	16	191	9606	9606.ENSP00000233893,9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000274063,9606.ENSP00000298139,9606.ENSP00000307272,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000321797,9606.ENSP00000333277,9606.ENSP00000371790,9606.ENSP00000372023,9606.ENSP00000376544,9606.ENSP00000378699,9606.ENSP00000381097,9606.ENSP00000478927	HSPE1,MDM2,BARD1,SFRP2,WRN,RPTOR,SUZ12,EZH2,FGF8,H3C13,FGF9,CHEK2,CD79B,CDK1,EPHB1,YAP1	9.62e-13	8.24e-07	(2020) Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
PMID	PMID:29642462	15	162	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000262965,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000331040,9606.ENSP00000360944,9606.ENSP00000368632,9606.ENSP00000378578,9606.ENSP00000405574,9606.ENSP00000405890,9606.ENSP00000406229,9606.ENSP00000432511,9606.ENSP00000451506	IFNG,MDM2,TCF3,SUZ12,EZH2,EBF1,OLIG2,STIL,GATA3,AFF1,TBL1XR1,PBX1,FAT1,JAK3,TCL1A	1.35e-12	8.24e-07	(2018) New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update.
PMID	PMID:27906827	11	55	9606	9606.ENSP00000053243,9606.ENSP00000229135,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000358501,9606.ENSP00000360181,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	TNFRSF17,IFNG,CD28,ICOSLG,STAT4,CD58,SH2D1A,TFRC,PRF1,TNF,CTLA4	8.14e-13	8.24e-07	(2017) Crosstalk Between T and B Cells in the Germinal Center After Transplantation.
PMID	PMID:27635407	11	55	9606	9606.ENSP00000053243,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000360181,9606.ENSP00000376197,9606.ENSP00000376786,9606.ENSP00000398698,9606.ENSP00000457991,9606.ENSP00000497102	TNFRSF17,CD28,IL21R,ICOSLG,STAT4,SH2D1A,TFRC,POU2AF1,TNF,PHLPP2,CTLA4	8.14e-13	8.24e-07	(2016) Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?
PMID	PMID:33024284	13	109	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000262965,9606.ENSP00000268712,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000363689,9606.ENSP00000376544,9606.ENSP00000376786	CD79A,IFNG,MDM2,TCF3,NCOR1,EZH2,EBF1,IL21R,ICOSLG,STAT4,ID3,CD79B,POU2AF1	2.4e-12	9.36e-07	(2021) Transcriptional regulation of memory B cell differentiation.
PMID	PMID:26165923	11	62	9606	9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000351255,9606.ENSP00000360181,9606.ENSP00000368632,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,EGR1,EGR2,CD28,H3C13,STAT4,SH2D1A,GATA3,PRF1,TNF,CTLA4	2.59e-12	9.36e-07	(2015) Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells.
PMID	PMID:33803671	12	85	9606	9606.ENSP00000268712,9606.ENSP00000275015,9606.ENSP00000279873,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000356832,9606.ENSP00000358501,9606.ENSP00000358799,9606.ENSP00000363689,9606.ENSP00000376544,9606.ENSP00000399168,9606.ENSP00000405574	NCOR1,NFKBIE,ARID5B,EZH2,EBF1,SGK1,CD58,RBM15,ID3,CD79B,HLA-B,TBL1XR1	2.86e-12	9.66e-07	(2021) Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas.
PMID	PMID:30158933	13	115	9606	9606.ENSP00000229135,9606.ENSP00000242480,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000360181,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000376786,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,EGR2,CD28,IL21R,ICOSLG,STAT4,SH2D1A,ID3,GATA3,POU2AF1,PRF1,TNF,CTLA4	4.48e-12	1.42e-06	(2018) Insights Into the Molecular Mechanisms of T Follicular Helper-Mediated Immunity and Pathology.
PMID	PMID:32630372	14	146	9606	9606.ENSP00000239938,9606.ENSP00000258149,9606.ENSP00000262741,9606.ENSP00000262995,9606.ENSP00000268053,9606.ENSP00000269571,9606.ENSP00000302961,9606.ENSP00000307272,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000339527,9606.ENSP00000356832,9606.ENSP00000441927,9606.ENSP00000457991	EGR1,MDM2,PIK3R3,GAB1,CYP11A1,ERBB2,HSPA4,RPTOR,EZH2,STK11,FOXO3,SGK1,SESN3,PHLPP2	5.06e-12	1.47e-06	(2020) The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.
PMID	PMID:33330058	13	116	9606	9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000263209,9606.ENSP00000269571,9606.ENSP00000295408,9606.ENSP00000320147,9606.ENSP00000332353,9606.ENSP00000352798,9606.ENSP00000360764,9606.ENSP00000368632,9606.ENSP00000376276,9606.ENSP00000398698,9606.ENSP00000478927	IFNG,EGR1,DGCR8,ERBB2,MERTK,EZH2,PTCH1,COL18A1,EGFL7,GATA3,SRSF2,TNF,YAP1	4.95e-12	1.47e-06	(2020) microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis.
PMID	PMID:32414833	14	149	9606	9606.ENSP00000229135,9606.ENSP00000261438,9606.ENSP00000275015,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339527,9606.ENSP00000351255,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,KLF3,NFKBIE,SUZ12,EZH2,CD28,IL21R,FOXO3,STAT4,ID3,GATA3,CDK1,TNF,CTLA4	6.52e-12	1.74e-06	(2020) Early precursors and molecular determinants of tissue-resident memory CD8(+) T lymphocytes revealed by single-cell RNA sequencing.
PMID	PMID:33120978	12	92	9606	9606.ENSP00000229135,9606.ENSP00000307272,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000351255,9606.ENSP00000356832,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000432511,9606.ENSP00000497102	IFNG,RPTOR,STK11,CD28,STAT4,SGK1,GATA3,TFRC,PRF1,TNF,JAK3,CTLA4	6.67e-12	1.74e-06	(2020) The Ups and Downs of Metabolism during the Lifespan of a T Cell.
PMID	PMID:37342324	12	96	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000269571,9606.ENSP00000324856,9606.ENSP00000332353,9606.ENSP00000360181,9606.ENSP00000368632,9606.ENSP00000376544,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	CD79A,IFNG,MDM2,ERBB2,STK11,PTCH1,SH2D1A,GATA3,CD79B,PRF1,TNF,CTLA4	1.05e-11	2.33e-06	(2023) The current advances of lncRNAs in breast cancer immunobiology research.
PMID	PMID:38199780	13	123	9606	9606.ENSP00000221972,9606.ENSP00000242480,9606.ENSP00000260947,9606.ENSP00000263464,9606.ENSP00000275015,9606.ENSP00000320147,9606.ENSP00000330349,9606.ENSP00000336701,9606.ENSP00000372023,9606.ENSP00000376276,9606.ENSP00000376544,9606.ENSP00000405574,9606.ENSP00000432511	CD79A,EGR2,BARD1,BIRC3,NFKBIE,EZH2,DDX41,RAD51C,CHEK2,SRSF2,CD79B,TBL1XR1,JAK3	9.76e-12	2.33e-06	(2023) PD-L1(+) diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation.
PMID	PMID:35657398	14	155	9606	9606.ENSP00000221972,9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000321797,9606.ENSP00000324856,9606.ENSP00000332353,9606.ENSP00000336701,9606.ENSP00000371790,9606.ENSP00000372023,9606.ENSP00000376197,9606.ENSP00000376544,9606.ENSP00000432511	CD79A,MDM2,BARD1,ERBB2,EZH2,FGF8,STK11,PTCH1,RAD51C,FGF9,CHEK2,TFRC,CD79B,JAK3	1.07e-11	2.33e-06	(2022) Somatic non-cancerous overgrowth syndrome of obscure molecular etiology: what are the causes and options?
PMID	PMID:36246629	14	155	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000321797,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000368632,9606.ENSP00000371790,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000410481,9606.ENSP00000497102	CD79A,IFNG,ERBB2,FGF8,CD28,ICOSLG,STAT4,GATA3,FGF9,TFRC,PRF1,TNF,LTB,CTLA4	1.07e-11	2.33e-06	(2022) The soldiers needed to be awakened: Tumor-infiltrating immune cells.
PMID	PMID:34195095	12	96	9606	9606.ENSP00000229135,9606.ENSP00000244537,9606.ENSP00000262662,9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000331040,9606.ENSP00000332353,9606.ENSP00000333277,9606.ENSP00000378699,9606.ENSP00000398568,9606.ENSP00000478927	IFNG,H4C6,CDKN2C,CDK2,ERBB2,EZH2,OLIG2,PTCH1,H3C13,CDK1,PRF1,YAP1	1.05e-11	2.33e-06	(2021) Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead.
PMID	PMID:34930377	11	71	9606	9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000336701,9606.ENSP00000339477,9606.ENSP00000339527,9606.ENSP00000354522,9606.ENSP00000372023,9606.ENSP00000378699,9606.ENSP00000497102	IFNG,ERBB2,STK11,CD28,RAD51C,ICOSLG,FOXO3,TOP1,CHEK2,CDK1,CTLA4	9.67e-12	2.33e-06	(2021) The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.
PMID	PMID:22528868	13	123	9606	9606.ENSP00000239938,9606.ENSP00000258149,9606.ENSP00000263209,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000338934,9606.ENSP00000339527,9606.ENSP00000360764,9606.ENSP00000362608,9606.ENSP00000368632,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000478927	EGR1,MDM2,DGCR8,ERBB2,EZH2,EZR,FOXO3,EGFL7,PIM1,GATA3,CDK1,TNF,YAP1	9.76e-12	2.33e-06	(2012) MicroRNAs and lung cancers: from pathogenesis to clinical implications.
PMID	PMID:35732829	12	98	9606	9606.ENSP00000263464,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000376544,9606.ENSP00000399168,9606.ENSP00000405574,9606.ENSP00000405890,9606.ENSP00000432511,9606.ENSP00000451506,9606.ENSP00000497102	BIRC3,EZH2,CD28,ID3,GATA3,CD79B,HLA-B,TBL1XR1,PBX1,JAK3,TCL1A,CTLA4	1.31e-11	2.37e-06	(2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
PMID	PMID:33468999	14	159	9606	9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000268058,9606.ENSP00000268712,9606.ENSP00000279873,9606.ENSP00000307199,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000333277,9606.ENSP00000358799,9606.ENSP00000365858,9606.ENSP00000376786,9606.ENSP00000378578,9606.ENSP00000379616	IFNG,TCF3,PML,NCOR1,ARID5B,AHSP,EZH2,EBF1,H3C13,RBM15,GATA1,POU2AF1,AFF1,MYH11	1.47e-11	2.56e-06	(2021) Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies.
PMID	PMID:37168665	10	53	9606	9606.ENSP00000053243,9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000351255,9606.ENSP00000368632,9606.ENSP00000376544,9606.ENSP00000398568,9606.ENSP00000398698	TNFRSF17,CD79A,IFNG,EBF1,CD28,STAT4,GATA3,CD79B,PRF1,TNF	1.54e-11	2.6e-06	(2023) Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles.
PMID	PMID:35454892	12	100	9606	9606.ENSP00000279873,9606.ENSP00000320147,9606.ENSP00000330349,9606.ENSP00000336752,9606.ENSP00000358799,9606.ENSP00000360944,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000376276,9606.ENSP00000379616,9606.ENSP00000432511,9606.ENSP00000498653	ARID5B,EZH2,DDX41,FIP1L1,RBM15,STIL,GATA1,GATA3,SRSF2,MYH11,JAK3,DEK	1.63e-11	2.6e-06	(2022) Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.
PMID	PMID:35732831	11	75	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000320147,9606.ENSP00000330349,9606.ENSP00000336752,9606.ENSP00000358799,9606.ENSP00000365858,9606.ENSP00000376276,9606.ENSP00000379616,9606.ENSP00000398698,9606.ENSP00000498653	CD79A,IFNG,EZH2,DDX41,FIP1L1,RBM15,GATA1,SRSF2,MYH11,TNF,DEK	1.65e-11	2.6e-06	(2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and HistiocyticDendritic Neoplasms.
PMID	PMID:35879299	13	128	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000263209,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000307272,9606.ENSP00000320147,9606.ENSP00000336701,9606.ENSP00000356832,9606.ENSP00000368632,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000478927	IFNG,MDM2,DGCR8,NCOR1,ERBB2,RPTOR,EZH2,RAD51C,SGK1,GATA3,CDK1,TNF,YAP1	1.55e-11	2.6e-06	(2022) Beyond controlling cell size: functional analyses of S6K in tumorigenesis.
PMID	PMID:36140723	14	160	9606	9606.ENSP00000260947,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000274063,9606.ENSP00000298139,9606.ENSP00000324856,9606.ENSP00000333277,9606.ENSP00000336701,9606.ENSP00000339527,9606.ENSP00000368632,9606.ENSP00000371790,9606.ENSP00000372023,9606.ENSP00000405574,9606.ENSP00000410402	BARD1,NCOR1,ERBB2,SFRP2,WRN,STK11,H3C13,RAD51C,FOXO3,GATA3,FGF9,CHEK2,TBL1XR1,MAP2K4	1.58e-11	2.6e-06	(2022) The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets.
PMID	PMID:32363322	12	100	9606	9606.ENSP00000053243,9606.ENSP00000229135,9606.ENSP00000310356,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000346001,9606.ENSP00000351255,9606.ENSP00000358501,9606.ENSP00000376786,9606.ENSP00000398698,9606.ENSP00000410481,9606.ENSP00000497102	TNFRSF17,IFNG,RMI2,CD28,IL21R,RPL3,STAT4,CD58,POU2AF1,TNF,LTB,CTLA4	1.63e-11	2.6e-06	(2020) Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis.
PMID	PMID:32608319	10	53	9606	9606.ENSP00000221972,9606.ENSP00000262965,9606.ENSP00000322898,9606.ENSP00000358501,9606.ENSP00000360944,9606.ENSP00000368632,9606.ENSP00000378578,9606.ENSP00000379616,9606.ENSP00000405890,9606.ENSP00000498653	CD79A,TCF3,EBF1,CD58,STIL,GATA3,AFF1,MYH11,PBX1,DEK	1.54e-11	2.6e-06	(2020) Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.
PMID	PMID:32117202	12	101	9606	9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000266970,9606.ENSP00000302961,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000339527,9606.ENSP00000368632,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,TCF3,CDK2,HSPA4,EZH2,STK11,CD28,H3C13,FOXO3,GATA3,TNF,CTLA4	1.81e-11	2.6e-06	(2019) Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation.
PMID	PMID:37673459	11	78	9606	9606.ENSP00000239938,9606.ENSP00000262965,9606.ENSP00000268712,9606.ENSP00000279873,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000363689,9606.ENSP00000378578,9606.ENSP00000405574,9606.ENSP00000405890,9606.ENSP00000432511	EGR1,TCF3,NCOR1,ARID5B,EZH2,EBF1,ID3,AFF1,TBL1XR1,PBX1,JAK3	2.42e-11	3.22e-06	(2023) Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia.
PMID	PMID:35328658	11	81	9606	9606.ENSP00000229135,9606.ENSP00000260947,9606.ENSP00000269571,9606.ENSP00000305480,9606.ENSP00000324890,9606.ENSP00000336701,9606.ENSP00000354522,9606.ENSP00000372023,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,BARD1,ERBB2,FEN1,CD28,RAD51C,TOP1,CHEK2,CDK1,TNF,CTLA4	3.5e-11	4.55e-06	(2022) Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
PMID	PMID:32350553	12	108	9606	9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000339477,9606.ENSP00000339527,9606.ENSP00000363689,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000497102	IFNG,TCF3,EZH2,CD28,H3C13,ICOSLG,FOXO3,ID3,GATA1,GATA3,TFRC,CTLA4	3.71e-11	4.6e-06	(2020) Transcriptional regulation of Treg homeostasis and functional specification.
PMID	PMID:29129997	8	24	9606	9606.ENSP00000229135,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000398698	IFNG,SUZ12,EZH2,EBF1,CD28,GATA1,GATA3,TNF	3.63e-11	4.6e-06	(2017) Trichloroethylene-induced alterations in DNA methylation were enriched in polycomb protein binding sites in effectormemory CD4(+) T cells.
PMID	PMID:26807257	8	24	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000302961,9606.ENSP00000324890,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000399168,9606.ENSP00000497102	IFNG,MDM2,HSPA4,CD28,PRF1,TNF,HLA-B,CTLA4	3.63e-11	4.6e-06	(2016) Focused ultrasound-aided immunomodulation in glioblastoma multiforme: a therapeutic concept.
PMID	PMID:35222432	12	109	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000242480,9606.ENSP00000262965,9606.ENSP00000306999,9606.ENSP00000322898,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000376276,9606.ENSP00000376544,9606.ENSP00000398698,9606.ENSP00000497102	CD79A,IFNG,EGR2,TCF3,ESCO2,EBF1,GATA1,GATA3,SRSF2,CD79B,TNF,CTLA4	4.09e-11	4.65e-06	(2022) Cohesin-Mediated Chromatin Interactions and Autoimmunity.
PMID	PMID:31484560	11	82	9606	9606.ENSP00000229135,9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000321797,9606.ENSP00000324890,9606.ENSP00000336701,9606.ENSP00000358501,9606.ENSP00000371790,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,CDK2,NCOR1,ERBB2,FGF8,CD28,RAD51C,CD58,FGF9,TNF,CTLA4	3.95e-11	4.65e-06	(2019) Emerging therapeutic agents for genitourinary cancers.
PMID	PMID:31572674	10	59	9606	9606.ENSP00000262965,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000358501,9606.ENSP00000360944,9606.ENSP00000378578,9606.ENSP00000405574,9606.ENSP00000405890,9606.ENSP00000494373	TCF3,SUZ12,EZH2,EBF1,CD58,STIL,AFF1,TBL1XR1,PBX1,MTAP	3.96e-11	4.65e-06	(2019) Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
PMID	PMID:22037603	9	40	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000244537,9606.ENSP00000262965,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000333277,9606.ENSP00000363689,9606.ENSP00000376544	CD79A,IFNG,H4C6,TCF3,SUZ12,EZH2,H3C13,ID3,CD79B	4.17e-11	4.65e-06	(2011) Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2.
PMID	PMID:24712463	12	110	9606	9606.ENSP00000229135,9606.ENSP00000263209,9606.ENSP00000266970,9606.ENSP00000302961,9606.ENSP00000307272,9606.ENSP00000324890,9606.ENSP00000339527,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000398698,9606.ENSP00000432511,9606.ENSP00000497102	IFNG,DGCR8,CDK2,HSPA4,RPTOR,CD28,FOXO3,GATA1,GATA3,TNF,JAK3,CTLA4	4.51e-11	4.86e-06	(2014) Treg functional stability and its responsiveness to the microenvironment.
PMID	PMID:37837931	11	84	9606	9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000333277,9606.ENSP00000378699,9606.ENSP00000380942,9606.ENSP00000411532,9606.ENSP00000478927,9606.ENSP00000494373,9606.ENSP00000497102	IFNG,ERBB2,SUZ12,EZH2,H3C13,CDK1,ARHGEF12,TOP2A,YAP1,MTAP,CTLA4	5e-11	5.27e-06	(2023) Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
PMID	PMID:28824851	9	41	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000358501,9606.ENSP00000376197,9606.ENSP00000378578,9606.ENSP00000405890	CD79A,IFNG,TCF3,EBF1,CD28,CD58,TFRC,AFF1,PBX1	5.06e-11	5.27e-06	(2016) Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy.
PMID	PMID:36119527	11	85	9606	9606.ENSP00000246868,9606.ENSP00000260947,9606.ENSP00000269571,9606.ENSP00000287598,9606.ENSP00000298139,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000332353,9606.ENSP00000336701,9606.ENSP00000356405,9606.ENSP00000372023	SBDS,BARD1,ERBB2,BUB1B,WRN,EZH2,STK11,PTCH1,RAD51C,CDC73,CHEK2	5.62e-11	5.68e-06	(2022) Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients.
PMID	PMID:37273190	11	86	9606	9606.ENSP00000053243,9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000360181,9606.ENSP00000376544,9606.ENSP00000376786,9606.ENSP00000398698,9606.ENSP00000410481	TNFRSF17,CD79A,IFNG,TCF3,CD28,IL21R,SH2D1A,CD79B,POU2AF1,TNF,LTB	6.3e-11	6.25e-06	(2023) Inborn errors of human B cell development, differentiation, and function.
PMID	PMID:32210163	16	257	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000336701,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000406229,9606.ENSP00000410402,9606.ENSP00000411532,9606.ENSP00000478927,9606.ENSP00000494373,9606.ENSP00000497102	CD79A,IFNG,MDM2,BARD1,CDK2,NCOR1,ERBB2,RAD51C,GATA3,CHEK2,FAT1,MAP2K4,TOP2A,YAP1,MTAP,CTLA4	6.38e-11	6.25e-06	(2020) Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments.
PMID	PMID:37298642	13	145	9606	9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000263464,9606.ENSP00000269571,9606.ENSP00000298139,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000336701,9606.ENSP00000356405,9606.ENSP00000372023,9606.ENSP00000432511,9606.ENSP00000451506,9606.ENSP00000498653	MDM2,BARD1,BIRC3,ERBB2,WRN,EZH2,STK11,RAD51C,CDC73,CHEK2,JAK3,TCL1A,DEK	6.57e-11	6.27e-06	(2023) Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications.
PMID	PMID:33604794	15	218	9606	9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000258149,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000321797,9606.ENSP00000339527,9606.ENSP00000356832,9606.ENSP00000364589,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000371790,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000405890	EGR1,EGR2,MDM2,ERBB2,EZH2,FGF8,FOXO3,SGK1,CUL4A,GATA1,GATA3,FGF9,CDK1,TNF,PBX1	7e-11	6.56e-06	(2021) Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors.
PMID	PMID:28477017	11	87	9606	9606.ENSP00000260947,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000279873,9606.ENSP00000324856,9606.ENSP00000336701,9606.ENSP00000339527,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000410402,9606.ENSP00000497102	BARD1,NCOR1,ERBB2,ARID5B,STK11,RAD51C,FOXO3,GATA3,CHEK2,MAP2K4,CTLA4	7.05e-11	6.56e-06	(2017) Characterization of potential driver mutations involved in human breast cancer by computational approaches.
PMID	PMID:28757603	11	87	9606	9606.ENSP00000229135,9606.ENSP00000266970,9606.ENSP00000302961,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000339527,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000432511,9606.ENSP00000497102	IFNG,CDK2,HSPA4,EZH2,CD28,H3C13,FOXO3,GATA1,GATA3,JAK3,CTLA4	7.05e-11	6.56e-06	(2017) The regulation of immune tolerance by FOXP3.
PMID	PMID:36609611	11	88	9606	9606.ENSP00000221972,9606.ENSP00000239938,9606.ENSP00000244537,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000378699,9606.ENSP00000411532,9606.ENSP00000451506,9606.ENSP00000494373,9606.ENSP00000497102,9606.ENSP00000498653	CD79A,EGR1,H4C6,EZH2,EBF1,CDK1,TOP2A,TCL1A,MTAP,CTLA4,DEK	7.89e-11	7e-06	(2023) Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richters transformation.
PMID	PMID:34958107	11	88	9606	9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000376276,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000399168,9606.ENSP00000432511,9606.ENSP00000497102	IFNG,ERBB2,SUZ12,EZH2,CD28,SRSF2,PRF1,TNF,HLA-B,JAK3,CTLA4	7.89e-11	7e-06	(2022) Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune-mediated bone marrow failure syndromes (Review).
PMID	PMID:34930302	13	148	9606	9606.ENSP00000229135,9606.ENSP00000244537,9606.ENSP00000266269,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000351255,9606.ENSP00000368632,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,H4C6,PATZ1,SUZ12,EZH2,STK11,CD28,H3C13,STAT4,GATA3,PRF1,TNF,CTLA4	8.33e-11	7e-06	(2021) Epigenetic modulation of antitumor immunity for improved cancer immunotherapy.
PMID	PMID:35582582	11	88	9606	9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000333277,9606.ENSP00000339527,9606.ENSP00000365858,9606.ENSP00000398698,9606.ENSP00000405574,9606.ENSP00000410402	CDK2,NCOR1,SUZ12,EZH2,STK11,H3C13,FOXO3,GATA1,TNF,TBL1XR1,MAP2K4	7.89e-11	7e-06	(2019) Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies.
PMID	PMID:29651429	11	88	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000263464,9606.ENSP00000269571,9606.ENSP00000321797,9606.ENSP00000331040,9606.ENSP00000352798,9606.ENSP00000371790,9606.ENSP00000372023,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,MDM2,BIRC3,ERBB2,FGF8,OLIG2,COL18A1,FGF9,CHEK2,TNF,CTLA4	7.89e-11	7e-06	(2018) Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.
PMID	PMID:36980578	11	89	9606	9606.ENSP00000258149,9606.ENSP00000262662,9606.ENSP00000266970,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000321797,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000371790,9606.ENSP00000378699,9606.ENSP00000497102	MDM2,CDKN2C,CDK2,SUZ12,EZH2,FGF8,CD28,H3C13,FGF9,CDK1,CTLA4	8.81e-11	7.12e-06	(2023) The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies.
PMID	PMID:37596643	12	117	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000263464,9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000307272,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000339527,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,MDM2,BIRC3,CDK2,ERBB2,RPTOR,EZH2,CD28,FOXO3,CDK1,TNF,CTLA4	8.73e-11	7.12e-06	(2023) PI3KAKTmTOR signaling transduction pathway and targeted therapies in cancer.
PMID	PMID:37649123	11	89	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000269571,9606.ENSP00000324890,9606.ENSP00000376276,9606.ENSP00000379616,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000399168,9606.ENSP00000497102,9606.ENSP00000498653	IFNG,MDM2,ERBB2,CD28,SRSF2,MYH11,PRF1,TNF,HLA-B,CTLA4,DEK	8.81e-11	7.12e-06	(2023) The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.
PMID	PMID:31798590	9	44	9606	9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000269571,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000376276,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,TCF3,ERBB2,EBF1,CD28,SRSF2,PRF1,TNF,CTLA4	8.8e-11	7.12e-06	(2019) Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies.
PMID	PMID:36542462	10	65	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000376544,9606.ENSP00000497102	CD79A,IFNG,EGR1,EGR2,CD28,ICOSLG,GATA3,TFRC,CD79B,CTLA4	9.33e-11	7.15e-06	(2023) scRNA-seq profiling of neonatal and adult thymus-derived CD4+ T cells by a T cell origin-time tracing model.
PMID	PMID:31544834	10	65	9606	9606.ENSP00000053243,9606.ENSP00000269571,9606.ENSP00000321797,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000371790,9606.ENSP00000376197,9606.ENSP00000376544,9606.ENSP00000398698,9606.ENSP00000497102	TNFRSF17,ERBB2,FGF8,CD28,ICOSLG,FGF9,TFRC,CD79B,TNF,CTLA4	9.33e-11	7.15e-06	(2019) David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments.
PMID	PMID:37193554	11	90	9606	9606.ENSP00000229135,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,SUZ12,EZH2,CD28,H3C13,ID3,GATA3,TFRC,PRF1,TNF,CTLA4	9.83e-11	7.32e-06	(2022) The functions of polycomb group proteins in T cells.
PMID	PMID:33777778	11	90	9606	9606.ENSP00000221972,9606.ENSP00000258149,9606.ENSP00000262965,9606.ENSP00000275364,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000356832,9606.ENSP00000358501,9606.ENSP00000358799,9606.ENSP00000376544,9606.ENSP00000405890	CD79A,MDM2,TCF3,GNA12,EZH2,EBF1,SGK1,CD58,RBM15,CD79B,PBX1	9.83e-11	7.32e-06	(2021) Mutational Profile and Clonal Evolution of RelapsedRefractory Diffuse Large B-Cell Lymphoma.
PMID	PMID:31555266	8	28	9606	9606.ENSP00000229135,9606.ENSP00000242480,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000324890,9606.ENSP00000333277,9606.ENSP00000365858	IFNG,EGR2,SUZ12,EZH2,EBF1,CD28,H3C13,GATA1	1.02e-10	7.32e-06	(2019) Continuous Developmental and Early Life Trichloroethylene Exposure Promoted DNA Methylation Alterations in Polycomb Protein Binding Sites in EffectorMemory CD4(+) T Cells.
PMID	PMID:22500835	11	90	9606	9606.ENSP00000221972,9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000262965,9606.ENSP00000266269,9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000322898,9606.ENSP00000365858,9606.ENSP00000376544,9606.ENSP00000376786	CD79A,IFNG,MDM2,TCF3,PATZ1,CDK2,NCOR1,EBF1,GATA1,CD79B,POU2AF1	9.83e-11	7.32e-06	(2012) POKZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.
PMID	PMID:37430137	10	66	9606	9606.ENSP00000260947,9606.ENSP00000264233,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000336701,9606.ENSP00000339527,9606.ENSP00000354522,9606.ENSP00000372023,9606.ENSP00000378699,9606.ENSP00000497102	BARD1,POLQ,ERBB2,EZH2,RAD51C,FOXO3,TOP1,CHEK2,CDK1,CTLA4	1.07e-10	7.51e-06	(2023) PARP inhibitors: enhancing efficacy through rational combinations.
PMID	PMID:35216666	10	66	9606	9606.ENSP00000229135,9606.ENSP00000252818,9606.ENSP00000261438,9606.ENSP00000262965,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000360181,9606.ENSP00000363689,9606.ENSP00000398698,9606.ENSP00000419153	IFNG,JUND,KLF3,TCF3,IL21R,ICOSLG,SH2D1A,ID3,TNF,ZBTB20	1.07e-10	7.51e-06	(2022) Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection.
PMID	PMID:36591286	10	66	9606	9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000363689,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,TCF3,CD28,IL21R,ICOSLG,ID3,TFRC,PRF1,TNF,CTLA4	1.07e-10	7.51e-06	(2022) Biology and clinical relevance of follicular cytotoxic T cells.
PMID	PMID:35303910	13	152	9606	9606.ENSP00000258149,9606.ENSP00000263464,9606.ENSP00000266970,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000333277,9606.ENSP00000358799,9606.ENSP00000372023,9606.ENSP00000376276,9606.ENSP00000398698,9606.ENSP00000399168,9606.ENSP00000405574,9606.ENSP00000432511	MDM2,BIRC3,CDK2,EZH2,EBF1,H3C13,RBM15,CHEK2,SRSF2,TNF,HLA-B,TBL1XR1,JAK3	1.13e-10	7.65e-06	(2022) Altered pathways and targeted therapy in double hit lymphoma.
PMID	PMID:34736527	13	152	9606	9606.ENSP00000221972,9606.ENSP00000252818,9606.ENSP00000262965,9606.ENSP00000268712,9606.ENSP00000307272,9606.ENSP00000322898,9606.ENSP00000339527,9606.ENSP00000363689,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000376544,9606.ENSP00000405890	CD79A,JUND,TCF3,NCOR1,RPTOR,EBF1,FOXO3,ID3,GATA1,GATA3,TFRC,CD79B,PBX1	1.13e-10	7.65e-06	(2021) The telomere complex and the origin of the cancer stem cell.
PMID	PMID:34281208	10	67	9606	9606.ENSP00000242480,9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000324856,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000398568,9606.ENSP00000497102	EGR2,MDM2,BARD1,NCOR1,ERBB2,STK11,GATA3,CHEK2,PRF1,CTLA4	1.22e-10	8.01e-06	(2021) Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.
PMID	PMID:33043516	11	92	9606	9606.ENSP00000258149,9606.ENSP00000263209,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000354522,9606.ENSP00000358464,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000478927,9606.ENSP00000494373	MDM2,DGCR8,ERBB2,EZH2,STK11,TOP1,SHOC2,CDK1,TNF,YAP1,MTAP	1.22e-10	8.01e-06	(2020) Cancer biology functional genomics: From small RNAs to big dreams.
PMID	PMID:33392513	9	46	9606	9606.ENSP00000239938,9606.ENSP00000262965,9606.ENSP00000279873,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000405574,9606.ENSP00000405890	EGR1,TCF3,ARID5B,EZH2,EBF1,ID3,GATA3,TBL1XR1,PBX1	1.25e-10	8.01e-06	(2020) Cell Fate Decisions: The Role of Transcription Factors in Early B-cell Development and Leukemia.
PMID	PMID:32746932	9	47	9606	9606.ENSP00000221972,9606.ENSP00000239938,9606.ENSP00000269571,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000351255,9606.ENSP00000364589,9606.ENSP00000365858	CD79A,EGR1,ERBB2,SUZ12,EZH2,CD28,STAT4,CUL4A,GATA1	1.48e-10	9.35e-06	(2020) Knowledge-primed neural networks enable biologically interpretable deep learning on single-cell sequencing data.
PMID	PMID:37387515	11	94	9606	9606.ENSP00000260947,9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000295408,9606.ENSP00000307272,9606.ENSP00000336701,9606.ENSP00000347409,9606.ENSP00000358799,9606.ENSP00000372023,9606.ENSP00000406229,9606.ENSP00000494373	BARD1,CDK2,ERBB2,MERTK,RPTOR,RAD51C,KEL,RBM15,CHEK2,FAT1,MTAP	1.51e-10	9.41e-06	(2023) Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
PMID	PMID:33806113	11	94	9606	9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000263209,9606.ENSP00000263464,9606.ENSP00000320147,9606.ENSP00000322898,9606.ENSP00000339527,9606.ENSP00000364589,9606.ENSP00000398698,9606.ENSP00000451506	IFNG,EGR1,EGR2,DGCR8,BIRC3,EZH2,EBF1,FOXO3,CUL4A,TNF,TCL1A	1.51e-10	9.41e-06	(2021) The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.
PMID	PMID:33680951	13	156	9606	9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000287598,9606.ENSP00000302961,9606.ENSP00000332353,9606.ENSP00000333277,9606.ENSP00000339527,9606.ENSP00000371790,9606.ENSP00000372023,9606.ENSP00000378699,9606.ENSP00000398698,9606.ENSP00000411532,9606.ENSP00000478927	CDK2,ERBB2,BUB1B,HSPA4,PTCH1,H3C13,FOXO3,FGF9,CHEK2,CDK1,TNF,TOP2A,YAP1	1.53e-10	9.41e-06	(2020) FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis.
PMID	PMID:30417146	11	94	9606	9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000324890,9606.ENSP00000339527,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000406229,9606.ENSP00000410481,9606.ENSP00000478927,9606.ENSP00000494373,9606.ENSP00000497102	IFNG,ERBB2,CD28,FOXO3,PRF1,TNF,FAT1,LTB,YAP1,MTAP,CTLA4	1.51e-10	9.41e-06	(2018) Immune and genomic signatures in oral (head and neck) cancer.
PMID	PMID:33741974	11	95	9606	9606.ENSP00000266970,9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000332353,9606.ENSP00000333277,9606.ENSP00000368632,9606.ENSP00000405890,9606.ENSP00000406229,9606.ENSP00000478927,9606.ENSP00000498653	CDK2,NCOR1,ERBB2,EZH2,PTCH1,H3C13,GATA3,PBX1,FAT1,YAP1,DEK	1.67e-10	9.67e-06	(2021) Epigenetic mechanisms in breast cancer therapy and resistance.
PMID	PMID:34298667	12	124	9606	9606.ENSP00000229135,9606.ENSP00000258149,9606.ENSP00000262741,9606.ENSP00000266970,9606.ENSP00000269571,9606.ENSP00000324890,9606.ENSP00000336701,9606.ENSP00000351255,9606.ENSP00000372023,9606.ENSP00000398698,9606.ENSP00000432511,9606.ENSP00000497102	IFNG,MDM2,PIK3R3,CDK2,ERBB2,CD28,RAD51C,STAT4,CHEK2,TNF,JAK3,CTLA4	1.63e-10	9.67e-06	(2021) Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma.
PMID	PMID:34736091	8	30	9606	9606.ENSP00000258149,9606.ENSP00000260947,9606.ENSP00000269571,9606.ENSP00000336701,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000376544,9606.ENSP00000410402	MDM2,BARD1,ERBB2,RAD51C,GATA3,CHEK2,CD79B,MAP2K4	1.63e-10	9.67e-06	(2021) Genetic heterogeneity during breast cancer progression in young patients.
PMID	PMID:26178856	8	30	9606	9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000262965,9606.ENSP00000324890,9606.ENSP00000360181,9606.ENSP00000363689,9606.ENSP00000368632	IFNG,EGR1,EGR2,TCF3,CD28,SH2D1A,ID3,GATA3	1.63e-10	9.67e-06	(2015) Zbtb16 (PLZF) is stably suppressed and not inducible in non-innate T cells via T cell receptor-mediated signaling.
PMID	PMID:37332039	16	276	9606	9606.ENSP00000053243,9606.ENSP00000229135,9606.ENSP00000262965,9606.ENSP00000269571,9606.ENSP00000320147,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000339527,9606.ENSP00000351255,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000432511,9606.ENSP00000497102	TNFRSF17,IFNG,TCF3,ERBB2,EZH2,CD28,IL21R,ICOSLG,FOXO3,STAT4,ID3,GATA3,PRF1,TNF,JAK3,CTLA4	1.73e-10	9.83e-06	(2023) T cells in health and disease.
PMID	PMID:31585620	13	158	9606	9606.ENSP00000262965,9606.ENSP00000268712,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000351255,9606.ENSP00000368632,9606.ENSP00000372023,9606.ENSP00000399168,9606.ENSP00000432511,9606.ENSP00000451506,9606.ENSP00000497102	TCF3,NCOR1,SUZ12,EZH2,STK11,CD28,STAT4,GATA3,CHEK2,HLA-B,JAK3,TCL1A,CTLA4	1.77e-10	9.96e-06	(2019) Genomics of LGL leukemia and select other rare leukemialymphomas.
PMID	PMID:28122577	12	126	9606	9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000258149,9606.ENSP00000266970,9606.ENSP00000320147,9606.ENSP00000331040,9606.ENSP00000363689,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000398698,9606.ENSP00000451506,9606.ENSP00000497102	EGR1,EGR2,MDM2,CDK2,EZH2,OLIG2,ID3,GATA1,GATA3,TNF,TCL1A,CTLA4	1.93e-10	1.07e-05	(2017) The Id-protein family in developmental and cancer-associated pathways.
PMID	PMID:36463323	9	49	9606	9606.ENSP00000229135,9606.ENSP00000269571,9606.ENSP00000302961,9606.ENSP00000324890,9606.ENSP00000352798,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000398698,9606.ENSP00000497102	IFNG,ERBB2,HSPA4,CD28,COL18A1,TFRC,PRF1,TNF,CTLA4	2.05e-10	1.12e-05	(2023) Ultrasound-targeted microbubble destruction remodels tumour microenvironment to improve immunotherapeutic effect.
PMID	PMID:35493515	10	71	9606	9606.ENSP00000229135,9606.ENSP00000307272,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000360181,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000398568,9606.ENSP00000497102	IFNG,RPTOR,CD28,ICOSLG,STAT4,SH2D1A,GATA3,TFRC,PRF1,CTLA4	2.04e-10	1.12e-05	(2022) Providing a Helping Hand: Metabolic Regulation of T Follicular Helper Cells and Their Association With Disease.
PMID	PMID:27211866	8	31	9606	9606.ENSP00000239938,9606.ENSP00000242480,9606.ENSP00000244537,9606.ENSP00000316578,9606.ENSP00000320147,9606.ENSP00000333277,9606.ENSP00000376276,9606.ENSP00000491215	EGR1,EGR2,H4C6,SUZ12,EZH2,H3C13,SRSF2,HNRNPU	2.04e-10	1.12e-05	(2016) RBFox2 Binds Nascent RNA to Globally Regulate Polycomb Complex 2 Targeting in Mammalian Genomes.
PMID	PMID:34084175	12	128	9606	9606.ENSP00000229135,9606.ENSP00000239938,9606.ENSP00000307272,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000324890,9606.ENSP00000339477,9606.ENSP00000339527,9606.ENSP00000351255,9606.ENSP00000363689,9606.ENSP00000368632,9606.ENSP00000497102	IFNG,EGR1,RPTOR,EZH2,STK11,CD28,ICOSLG,FOXO3,STAT4,ID3,GATA3,CTLA4	2.28e-10	1.22e-05	(2021) Canonical Secretomes, Innate Immune Caspase-1-, 411-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways.
PMID	PMID:31141692	10	72	9606	9606.ENSP00000268712,9606.ENSP00000269571,9606.ENSP00000279873,9606.ENSP00000287598,9606.ENSP00000356405,9606.ENSP00000368632,9606.ENSP00000398568,9606.ENSP00000399168,9606.ENSP00000406229,9606.ENSP00000410402	NCOR1,ERBB2,ARID5B,BUB1B,CDC73,GATA3,PRF1,HLA-B,FAT1,MAP2K4	2.31e-10	1.22e-05	(2019) The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.
PMID	PMID:26800764	10	72	9606	9606.ENSP00000262965,9606.ENSP00000269571,9606.ENSP00000305480,9606.ENSP00000320147,9606.ENSP00000324856,9606.ENSP00000378578,9606.ENSP00000379616,9606.ENSP00000405890,9606.ENSP00000432511,9606.ENSP00000498653	TCF3,ERBB2,FEN1,EZH2,STK11,AFF1,MYH11,PBX1,JAK3,DEK	2.31e-10	1.22e-05	(2016) Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.
PMID	PMID:34691592	9	50	9606	9606.ENSP00000221972,9606.ENSP00000261438,9606.ENSP00000322898,9606.ENSP00000331040,9606.ENSP00000339527,9606.ENSP00000365858,9606.ENSP00000368632,9606.ENSP00000376197,9606.ENSP00000376544	CD79A,KLF3,EBF1,OLIG2,FOXO3,GATA1,GATA3,TFRC,CD79B	2.41e-10	1.24e-05	(2021) Single-cell transcriptomic landscape of human blood cells.
PMID	PMID:32414002	9	50	9606	9606.ENSP00000239938,9606.ENSP00000246868,9606.ENSP00000258149,9606.ENSP00000320147,9606.ENSP00000330349,9606.ENSP00000333277,9606.ENSP00000372023,9606.ENSP00000376276,9606.ENSP00000497102	EGR1,SBDS,MDM2,EZH2,DDX41,H3C13,CHEK2,SRSF2,CTLA4	2.41e-10	1.24e-05	(2020) TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings.
PMID	PMID:22753927	9	50	9606	9606.ENSP00000229135,9606.ENSP00000324890,9606.ENSP00000338010,9606.ENSP00000339477,9606.ENSP00000351255,9606.ENSP00000360181,9606.ENSP00000368632,9606.ENSP00000398568,9606.ENSP00000497102	IFNG,CD28,IL21R,ICOSLG,STAT4,SH2D1A,GATA3,PRF1,CTLA4	2.41e-10	1.24e-05	(2012) The origins, function, and regulation of T follicular helper cells.
